🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial Infection

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00303-20Source: DataRank Database

Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial Infection is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)OA: greenTopics (53)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Lina Zhang ORCID,Sondus Alkhazraji,Yiyou Gu ORCID,Eman G. Youssef ORCID,Zongzhong Tong

Live enrichment

PubMed:32393494 PMC:PMC7526831

HHS | National Institutes of Health

Grant: 2R44 HL127886-02A1

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01 AI063503

NIAMS NIH HHS

Grant: R01 AR064788

HHS | National Institutes of Health

Grant: R01 CA202778

HHS | National Institutes of Health

Grant: R01 EY025342

NIAID NIH HHS

Grant: R21 AI119339

HHS | National Institutes of Health

Grant: UL1TR000124

HHS | National Institutes of Health

Grant: 5R44 HL127886-03

ARF6 Inhibitors for Treatment of Acute Lung Injury

NIAID NIH HHS

Grant: R01 AI141202

HHS | National Institutes of Health

Grant: R01 HL130541

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R22-R33 AI119339

HHS | National Institutes of Health

Grant: 1R43 HL127886-01

HHS | National Institutes of Health

Grant: R01 HL077671

NIAID NIH HHS

Grant: R33 AI119339

NHLBI NIH HHS

Grant: R43 HL127886

NHLBI NIH HHS

Grant: R44 HL127886

NCATS NIH HHS

Grant: UL1 TR001881

National Institutes of Health

Grant: 1R01HL130541-01A1

New Therapies to Restore Vascular Integrity During Sepsis

National Institutes of Health

Grant: 4R33AI119339-03

Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections

National Institutes of Health

Grant: 5UL1TR000124-04

UCLA Clinical and Translational Science Institute

National Institutes of Health

Grant: 2R01HL077671-09

Endothelial Toll-Like Receptor Signaling and Inflammation

National Institutes of Health

Grant: 5R01AI063503-12

Novel Toxins and Receptors in Mucormycosis Pathogenesis

National Institutes of Health

Grant: 1R01AR064788-01

The Role of the Vasculature in the Pathogenesis of Arthritis

National Institutes of Health

Grant: 5R01EY025342-05

Targeting ARF6, A Convergence Point For Multiple Pathways of Diabetic Retinopathy

National Institutes of Health

Grant: 5R01CA202778-02

Identifying a nodal point for G alpha q signaling in eye disease

greenLicense: ASM Journals Non-Commercial TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7526831

https://doi.org/10.1128/aac.00303-20

https://aac.asm.org/content/aac/64/8/e00303-20.full.pdf

https://pubmed.ncbi.nlm.nih.gov/32393494

https://dx.doi.org/10.1128/aac.00303-20

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsMiceGram-Negative BacteriaAcinetobacter baumanniiPseudomonas aeruginosaGram-Negative Bacterial InfectionsAnti-Bacterial AgentsMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialADP-Ribosylation Factor 6

Keywords

Pseudomonas aeruginosaDrug resistanceKlebsiella pneumoniaeLPSAcinetobacter baumanniiLipopolysaccharideMultidrug resistanceSepsisGram-negative BacteriaVascular PermeabilityArf6Clinical Sciences610Microbial Sensitivity TestsMicrobiologyMiceRare DiseasesBiodefenseDrug Resistance, Multiple, Bacterial6162.1 Biological and endogenous factorsAnimalsLungBiomedical and Clinical SciencesBacterialHematologyPneumoniaPharmacology and Pharmaceutical SciencesMedical microbiologyAnti-Bacterial AgentsInfectious DiseasesEmerging Infectious DiseasesGood Health and Well Being5.1 PharmaceuticalsADP-Ribosylation Factor 6Pneumonia & InfluenzaAntimicrobial ResistanceInfectionGram-Negative Bacterial InfectionsMultiple

Sustainable Development Goals

SDG 3: 3. Good health